Structural Mechanisms of NLRP3 Inflammasome Assembly and Activation

被引:370
|
作者
Fu, Jianing [1 ,2 ]
Wu, Hao [1 ,2 ]
机构
[1] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA
[2] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02215 USA
基金
美国国家卫生研究院;
关键词
NLRP3; ASC; caspase-1; inflammasomes; filaments; structures; GASDERMIN-D; PYRIN DOMAIN; NEK7; KINASE; CASPASE RECRUITMENT; CRYSTAL-STRUCTURE; CELL-DEATH; PROTEIN; ASC; IL-1-BETA; IL-18;
D O I
10.1146/annurev-immunol-081022-021207
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
As an important sensor in the innate immune system, NLRP3 detects exogenous pathogenic invasions and endogenous cellular damage and responds by forming the NLRP3 inflammasome, a supramolecular complex that activates caspase-1. The three major components of the NLRP3 inflammasome are NLRP3, which captures the danger signals and recruits downstream molecules; caspase-1, which elicits maturation of the cytokines IL-1 beta and IL-18 and processing of gasdermin D to mediate cytokine release and pyroptosis; and ASC (apoptosis-associated speck-like protein containing a caspase recruitment domain), which functions as a bridge connecting NLRP3 and caspase-1. In this article, we review the structural information that has been obtained on the NLRP3 inflammasome and its components or subcomplexes, with special focus on the inactive NLRP3 cage, the active NLRP3-NEK7 (NIMA-related kinase 7)-ASC inflammasome disk, and the PYD-PYD and CARD-CARD homotypic filamentous scaffolds of the inflammasome. We further implicate structure-derived mechanisms for the assembly and activation of the NLRP3 inflammasome.
引用
收藏
页码:301 / 316
页数:16
相关论文
共 50 条
  • [31] Increasing complexity of NLRP3 inflammasome regulation
    Moretti, Julien
    Blander, J. Magarian
    JOURNAL OF LEUKOCYTE BIOLOGY, 2021, 109 (03) : 561 - 571
  • [32] Atranorin inhibits NLRP3 inflammasome activation by targeting ASC and protects NLRP3 inflammasome-driven diseases
    Hao-yu Wang
    Xi Lin
    Guan-gen Huang
    Rong Zhou
    Shu-yue Lei
    Jing Ren
    Kai-rong Zhang
    Chun-lan Feng
    Yan-wei Wu
    Wei Tang
    Acta Pharmacologica Sinica, 2023, 44 : 1687 - 1700
  • [33] Atranorin inhibits NLRP3 inflammasome activation by targeting ASC and protects NLRP3 inflammasome-driven diseases
    Wang, Hao-yu
    Lin, Xi
    Huang, Guan-gen
    Zhou, Rong
    Lei, Shu-yue
    Ren, Jing
    Zhang, Kai-rong
    Feng, Chun-lan
    Wu, Yan-wei
    Tang, Wei
    ACTA PHARMACOLOGICA SINICA, 2023, 44 (08) : 1687 - 1700
  • [34] Celastrol specifically inhibits the activation of NLRP3 inflammasome
    Xuesong Sang
    Yihui Chen
    Wei Chen
    Jing Xie
    Guangxun Meng
    Jin Zhong
    Taisheng Li
    Ailing Lu
    Science China(Life Sciences) , 2018, (03) : 355 - 357
  • [35] The Role of Melatonin on NLRP3 Inflammasome Activation in Diseases
    Arioz, Burak Ibrahim
    Tarakcioglu, Emre
    Olcum, Melis
    Genc, Sermin
    ANTIOXIDANTS, 2021, 10 (07)
  • [36] The NLRP3 inflammasome in depression: Potential mechanisms and therapies
    Xia, Cong-Yuan
    Guo, Yu-Xuan
    Lian, Wen-Wen
    Yan, Yu
    Ma, Bing-Zhi
    Cheng, Yung -Chi
    Xu, Jie-Kun
    He, Jun
    Zhang, Wei -Ku
    PHARMACOLOGICAL RESEARCH, 2023, 187
  • [37] NLRP3 Inflammasome Activation Induced by Engineered Nanomaterials
    Sun, Bingbing
    Wang, Xiang
    Ji, Zhaoxia
    Li, Ruibin
    Xia, Tian
    SMALL, 2013, 9 (9-10) : 1595 - 1607
  • [38] NLRP3 inflammasome in atherosclerosis: Mechanisms and targeted therapies
    Chen, Pengfei
    Li, Xia
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [39] Activation of the NLRP3 Inflammasome by Proteins That Signal for Necroptosis
    Kang, Tae-Bong
    Yang, Seung-Hoon
    Toth, Beata
    Kovalenko, Andrew
    Wallach, David
    REGULATED CELL DEATH, PT B: NECROPTOTIC, AUTOPHAGIC AND OTHER NON-APOPTOTIC MECHANISMS, 2014, 545 : 67 - 81
  • [40] NLRP3 Inflammasome Activation by Viroporins of Animal Viruses
    Guo, Hui-Chen
    Jin, Ye
    Zhi, Xiao-Yin
    Yan, Dan
    Sun, Shi-Qi
    VIRUSES-BASEL, 2015, 7 (07): : 3380 - 3391